Becotatugvedotin Plus Pucotenlimab in EGFR-Positive Advanced Gastric/GEJ Adenocarcinoma

NCT07692334 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer
Gastroesophageal Junction (GEJ) Adenocarcinoma
Becotatug Vedotin
Pucotenlimab

Interventions

DRUG: Becotatug Vedotin (MRG003)
DRUG: Pucotenlimab

Sponsor

West China Second University Hospital